サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1552641

脳神経外科の世界市場：産業分析、規模、シェア、成長、動向、予測、2024-2034年

Neurosurgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日: | 発行: Transparency Market Research | ページ情報: 英文 142 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
脳神経外科の世界市場：産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年07月11日
発行: Transparency Market Research
ページ情報: 英文 142 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳神経外科市場- 調査範囲

TMRの調査レポート「脳神経外科の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の脳神経外科市場の収益と予測を提供しています。また、2024年から2034年までの世界の脳神経外科市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、脳神経外科市場を推察しました。

市場スナップショット
2023年の市場規模 42億米ドル
2034年の市場規模 68億米ドル
CAGR 4.5%

当レポートでは、世界の脳神経外科市場の競合情勢について調査しています。世界の脳神経外科市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の脳神経外科市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：製品タイプ別、2020-2034年
    • 神経介入デバイス
    • 神経内視鏡
    • 脳神経外科用ドリル
    • 放射線手術システム
    • 硬膜代替品
    • 脳神経外科用アブレーション装置
    • 機器
  • 市場の魅力分析：製品タイプ別

第7章 世界の市場分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：適応症別、2020-2034年
    • 脳腫瘍
    • 脊椎・頭蓋底腫瘍
    • 外傷性脳損傷
    • 頭蓋顔面外傷
    • パーキンソン病
    • トゥレット症候群
    • その他（頭蓋骨癒合症など）
  • 市場の魅力分析：適応症別

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：エンドユーザー別、2020-2034年
    • 病院・専門クリニック
    • 外来手術センター
    • その他（学術・専門神経学研究所など）
  • 市場の魅力分析：エンドユーザー別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020-2034年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋地域の市場分析と予測

第13章 ラテンアメリカの市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業- 競争マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023）
  • 企業プロファイル
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Elekta
    • Aleva Neurotherapeutics
    • Machida Endoscope Co., Ltd.
    • Brainlab
    • adeor Medical AG
    • LivaNova, plc
    • B. Braun
    • Optofine Instruments Pvt. Ltd.
    • Wallaby Medical, LLC
    • Terumo Medical Corporation
    • Integra LifeSciences
    • Stryker Tech
図表

List of Tables

  • Table 1: Global Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 2: Global Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 3: Global Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 4: Global Neurosurgery Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 5: North America Neurosurgery Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 6: North America Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 7: North America Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 8: North America Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 9: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 11: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 12: Europe Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 15: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 16: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 19: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 20: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 23: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 24: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 1: Global Neurosurgery Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 2: Global Neurosurgery Market Revenue (US$ Bn), by Product Type, 2023
  • Figure 3: Global Neurosurgery Market Value Share, by Product Type, 2023
  • Figure 4: Global Neurosurgery Market Revenue (US$ Bn), by Indication Type, 2023
  • Figure 5: Global Neurosurgery Market Value Share, by Indication Type, 2023
  • Figure 6: Global Neurosurgery Market Revenue (US$ Bn), by End-user, 2023
  • Figure 7: Global Neurosurgery Market Value Share, by End-user, 2023
  • Figure 8: Global Neurosurgery Market Value Share, by Region, 2023
  • Figure 9: Global Neurosurgery Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 11: Global Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 13: Global Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 14: Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Neurosurgery Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Neurosurgery Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Neurosurgery Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 22: North America Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 23: North America Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 26: North America Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 31: Europe Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 32: Europe Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 35: Europe Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 40: Asia Pacific Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 41: Asia Pacific Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 44: Asia Pacific Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 49: Latin America Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 50: Latin America Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 53: Latin America Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
  • Figure 58: Middle East & Africa Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 59: Middle East & Africa Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 62: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86326

Neurosurgery Market - Scope of Report

TMR's report on the global neurosurgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global neurosurgery market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurosurgery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the neurosurgery market.

Market Snapshot
Market Value in 2023US$ 4.2 Bn
Market Value in 2034US$ 6.8 Bn
CAGR4.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurosurgery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurosurgery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurosurgery market.

The report delves into the competitive landscape of the global neurosurgery market. Key players operating in the global neurosurgery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurosurgery market profiled in this report.

Key Questions Answered in Global neurosurgery Market Report:

  • What is the sales/revenue generated by neurosurgery across all regions during the forecast period?
  • What are the opportunities in the global neurosurgery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Neurosurgery Market - Research Objectives and Research Approach

The comprehensive report on the global neurosurgery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurosurgery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurosurgery market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Neurosurgery Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Neurosurgery Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Neurosurgery Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020-2034
    • 6.3.1. Neuro Interventional Devices
    • 6.3.2. Neuroendoscopes
    • 6.3.3. Neurosurgical Drills
    • 6.3.4. Radiosurgery Systems
    • 6.3.5. Dura Substitutes
    • 6.3.6. Neurosurgical Ablation Devices
    • 6.3.7. Neurosurgery Instruments
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Neurosurgery Market Analysis and Forecast, by Indication Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication Type, 2020-2034
    • 7.3.1. Brain Cancer
    • 7.3.2. Spine and Skull base Tumors
    • 7.3.3. Traumatic Brain Injuries
    • 7.3.4. Craniofacial Trauma
    • 7.3.5. Parkinson's Disease
    • 7.3.6. Tourette's Syndrome
    • 7.3.7. Others (Craniosynostosis, etc.)
  • 7.4. Market Attractiveness Analysis, by Indication Type

8. Global Neurosurgery Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Neurosurgery Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Neurosurgery Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2020-2034
    • 10.3.1. Neuro Interventional Devices
    • 10.3.2. Neuroendoscopes
    • 10.3.3. Neurosurgical Drills
    • 10.3.4. Radiosurgery Systems
    • 10.3.5. Dura Substitutes
    • 10.3.6. Neurosurgical Ablation Devices
    • 10.3.7. Neurosurgery Instruments
  • 10.4. Market Value Forecast, by Indication Type, 2020-2034
    • 10.4.1. Brain Cancer
    • 10.4.2. Spine and Skull base Tumors
    • 10.4.3. Traumatic Brain Injuries
    • 10.4.4. Craniofacial Trauma
    • 10.4.5. Parkinson's Disease
    • 10.4.6. Tourette's Syndrome
    • 10.4.7. Others (Craniosynostosis, etc.)
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals & Specialty Clinics
    • 10.5.2. Ambulatory Surgical Centers
    • 10.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Indication Type
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Neurosurgery Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2020-2034
    • 11.3.1. Neuro Interventional Devices
    • 11.3.2. Neuroendoscopes
    • 11.3.3. Neurosurgical Drills
    • 11.3.4. Radiosurgery Systems
    • 11.3.5. Dura Substitutes
    • 11.3.6. Neurosurgical Ablation Devices
    • 11.3.7. Neurosurgery Instruments
  • 11.4. Market Value Forecast, by Indication Type, 2020-2034
    • 11.4.1. Brain Cancer
    • 11.4.2. Spine and Skull base Tumors
    • 11.4.3. Traumatic Brain Injuries
    • 11.4.4. Craniofacial Trauma
    • 11.4.5. Parkinson's Disease
    • 11.4.6. Tourette's Syndrome
    • 11.4.7. Others (Craniosynostosis, etc.)
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals & Specialty Clinics
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Indication Type
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Neurosurgery Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2020-2034
    • 12.3.1. Neuro Interventional Devices
    • 12.3.2. Neuroendoscopes
    • 12.3.3. Neurosurgical Drills
    • 12.3.4. Radiosurgery Systems
    • 12.3.5. Dura Substitutes
    • 12.3.6. Neurosurgical Ablation Devices
    • 12.3.7. Neurosurgery Instruments
  • 12.4. Market Value Forecast, by Indication Type, 2020-2034
    • 12.4.1. Brain Cancer
    • 12.4.2. Spine and Skull base Tumors
    • 12.4.3. Traumatic Brain Injuries
    • 12.4.4. Craniofacial Trauma
    • 12.4.5. Parkinson's Disease
    • 12.4.6. Tourette's Syndrome
    • 12.4.7. Others (Craniosynostosis, etc.)
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals & Specialty Clinics
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Indication Type
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Neurosurgery Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2020-2034
    • 13.3.1. Neuro Interventional Devices
    • 13.3.2. Neuroendoscopes
    • 13.3.3. Neurosurgical Drills
    • 13.3.4. Radiosurgery Systems
    • 13.3.5. Dura Substitutes
    • 13.3.6. Neurosurgical Ablation Devices
    • 13.3.7. Neurosurgery Instruments
  • 13.4. Market Value Forecast, by Indication Type, 2020-2034
    • 13.4.1. Brain Cancer
    • 13.4.2. Spine and Skull base Tumors
    • 13.4.3. Traumatic Brain Injuries
    • 13.4.4. Craniofacial Trauma
    • 13.4.5. Parkinson's Disease
    • 13.4.6. Tourette's Syndrome
    • 13.4.7. Others (Craniosynostosis, etc.)
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals & Specialty Clinics
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Indication Type
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Neurosurgery Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2020-2034
    • 14.3.1. Neuro Interventional Devices
    • 14.3.2. Neuroendoscopes
    • 14.3.3. Neurosurgical Drills
    • 14.3.4. Radiosurgery Systems
    • 14.3.5. Dura Substitutes
    • 14.3.6. Neurosurgical Ablation Devices
    • 14.3.7. Neurosurgery Instruments
  • 14.4. Market Value Forecast, by Indication Type, 2020-2034
    • 14.4.1. Brain Cancer
    • 14.4.2. Spine and Skull base Tumors
    • 14.4.3. Traumatic Brain Injuries
    • 14.4.4. Craniofacial Trauma
    • 14.4.5. Parkinson's Disease
    • 14.4.6. Tourette's Syndrome
    • 14.4.7. Others (Craniosynostosis, etc.)
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals & Specialty Clinics
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Indication Type
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Medtronic plc
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Abbott Laboratories
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Boston Scientific Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Elekta
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Aleva Neurotherapeutics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Machida Endoscope Co., Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Brainlab
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. adeor Medical AG
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. LivaNova, plc
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. B. Braun
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Optofine Instruments Pvt. Ltd.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Wallaby Medical, LLC
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Terumo Medical Corporation
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. Integra LifeSciences
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview
    • 15.3.15. Stryker Tech
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Product Portfolio
      • 15.3.15.3. SWOT Analysis
      • 15.3.15.4. Financial Overview
      • 15.3.15.5. Strategic Overview